alexa Preclinical And Clinical Testing Of A Alpha-ketoglutarate/5-HMF/N-actyl-selenomethionine And N-acteyl-methionine For Treating Tumors | 15839
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd World Congress on Cancer Science & Therapy

Joachim Greilberger
ScientificTracks: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.028
Abstract
This lecture will address of the use of a newly developed therapeutic substance combination (KARAL?) namely alpha-ketoglutarate (AKG)/5-Hydroxymethylfurfurale (5-HMF)/N-Acetyl-Selenomethionine (NASeLM) and N-Acteyl-methionine (NALM). Supplementation of of AKG/5-HMF alone (Sanopal?, CYL-Phamraceutica) was used in a clinical study as pre-operative solution in patients with lung cancer. Results showed significant reduction of complications during surgery, massive better conditions before and after surgery (reduction of hospitalization +/- 11 days) compared to control group. Single substances, and combination of all substances in several concentrations showed on cancer cells (Jurkat, non-small cancer cells, thyroid cancer cells, prostate cancer cells) concentration dependent decrease of mitochondrial activity, cell growth and an increase of caspase-3 activity. In two pre-clinical studies (cancer in lung, pleura and esophagus and prostate cancer) on the Medical University of Graz and on the Medical University of Vienna promising results ratify the outcomes of cell studies.
Biography
Joachim Greilberger has studied medicinal chemistry, medicinal biochemistry and clinical chemistry of cancer cells, but also in other diseases like neurodegenerative diseases, atherosclerosis or diabetes. He is involved in the development of novel combined substances for treating tumors, like non-small cancer lung cells, esophagus, pleura, prostate in clinical trials and also in cell culture. He is also involved in the development of oxidative stress parameters, like damaged proteins (carbonylated proteins, nitrated proteins), during cancerogenesis.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7